Diabetes and chronic heart failure are interrelated conditions with major medical and economic impact that have to be treated as a distinct entity. Several pathological mechanisms have been investigated and proposed to explain the structural and functional changes associated with diabetic cardiomyopathy. These mechanisms are likely to act synergically and may potentiate one the other. This review outlines recent advances in the pathophysiological mechanisms implicated in the development and progression of diabetic cardiomyopathy and in current therapeutic strategies.
Diabetes and chronic heart failure: from diabetic cardiomyopathy to therapeutic approach / DEI CAS, Alessandra; Spigoni, Valentina; V., Ridolfi; M., Metra. - In: ENDOCRINE, METABOLIC & IMMUNE DISORDERS DRUG TARGETS. - ISSN 1871-5303. - 13:(2013), pp. 38-50. [10.2174/1871530311313010006]
Diabetes and chronic heart failure: from diabetic cardiomyopathy to therapeutic approach.
DEI CAS, Alessandra;SPIGONI, Valentina;
2013-01-01
Abstract
Diabetes and chronic heart failure are interrelated conditions with major medical and economic impact that have to be treated as a distinct entity. Several pathological mechanisms have been investigated and proposed to explain the structural and functional changes associated with diabetic cardiomyopathy. These mechanisms are likely to act synergically and may potentiate one the other. This review outlines recent advances in the pathophysiological mechanisms implicated in the development and progression of diabetic cardiomyopathy and in current therapeutic strategies.| File | Dimensione | Formato | |
|---|---|---|---|
|
Therapeutic targets.pdf
non disponibili
Tipologia:
Documento in Post-print
Licenza:
NON PUBBLICO - Accesso privato/ristretto
Dimensione
279.86 kB
Formato
Adobe PDF
|
279.86 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
